UK markets closed

GENE Sep 2024 2.500 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.70000.0000 (0.00%)
At close: 11:52AM EDT
Full screen
Previous close0.7000
Open1.2200
Bid0.0000
Ask2.4000
Strike2.50
Expiry date2024-09-20
Day's range0.7000 - 1.2200
Contract rangeN/A
Volume10
Open interest11
  • GlobeNewswire

    GTG Launches Revolutionary geneType Test covering 100% Risk of Breast and Ovarian Cancer

    MELBOURNE, Australia, May 29, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and serious disease, is pleased to announce the Company has released its novel Comprehensive Risk Assessment test that covers 100% of women at risk of developing breast and ovarian cancer. The innovative test, available to all women above the age of 30, assesses a woman’s risk of cancer due to hereditary, inclu

  • GlobeNewswire

    GeneType and Humanise Health host “Know Your Risk” Event

    PASADENA, Calif., May 23, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GeneType”), a global leader in genomics-based tests in health, wellness and serious disease, is pleased to announce that the Know Your Risk event held yesterday at The Langham Pasadena has set a new standard for women’s health initiatives, highlighting the transformative potential of genetic testing and risk assessment. Organized by GeneType and Humanise Health, in partnership wit

  • GlobeNewswire

    GTG and ‘Wellworks for You’ sign B2B sales & marketing deal covering 750 employer groups and 2 million U.S. employees

    MELBOURNE, Australia, May 06, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and serious disease, is pleased to announce the execution of a strategic joint sales & marketing agreement with US based Wellworks for You Inc. (Wellworks). As part of the agreement, Wellworks will incorporate the geneType portfolio of tests into its fully flexible, scalable employee wellness solutions for orga